<address id="3xt9h"></address>

        <form id="3xt9h"></form>

          [Skip to Content]
          [Skip to Content Landing]
          Views 409
          Citations 0
          Special Communication
          November?18, 2020

          Leveraging Basic Science for the Clinic—From Bench to Bedside

          Author Affiliations
          • 1Clinical Neuroscience Research Unit, Department of Psychiatry, Yale University, School of Medicine, New Haven, Connecticut
          • 2National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland
          JAMA Psychiatry. Published online November 18, 2020. doi:10.1001/jamapsychiatry.2020.3656
          Abstract

          Importance? The tools and insights of behavioral neuroscience grow apace, yet their clinical application is lagging.

          Observations? This article suggests that associative learning theory may be the algorithmic bridge to connect a burgeoning understanding of the brain with the challenges to the mind with which all clinicians and researchers are concerned.

          Conclusions and Relevance? Instead of giving up, talking past one another, or resting on the laurels of face validity, a consilient and collaborative approach is suggested: visiting laboratory meetings and clinical rounds and attempting to converse in the language of behavior and cognition to better understand and ultimately treat patients.

          Limit 200 characters
          Limit 25 characters
          Conflicts of Interest Disclosure

          Identify all potential conflicts of interest that might be relevant to your comment.

          Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

          Err on the side of full disclosure.

          If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

          Not all submitted comments are published. Please see our commenting policy for details.

          Limit 140 characters
          Limit 3600 characters or approximately 600 words
            1 Comment for this article
            EXPAND ALL
            Where are the biomarkers?
            David Lewis |
            This article makes it sound like the lack of clinical applications of purported revolutionary insights of neuroscience into psychopathology is a failure of communication, ingenuity or will.

            But if so, why are there no clinically actionable biomarkers for psychiatric disorders -- none, zero -- based on any neuro-technology, biochemical or image-based!

            Sorry, but if brain science can't even reliably diagnose an individual's depression or predict the course of a schizophrenia patient's symptoms under various treatments, then the science just isn't there for any clinical application, diagnostic, prognostic or therapeutic. Worse, to hope or predict that such
            success might arrive with "tools on the horizon" is not science but pseudo-scientific wishful thinking, especially given the failure so far.
            CONFLICT OF INTEREST: None Reported
            READ MORE
            ×
            4887王中王鉄算 盘开奖结果小说